Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299 Arg substitutions in factor V

British Journal of Haematology

Volumn 99, Issue 2, 1997, Pages 257-261

  Castaman, Giancarlo ^a   Lunghi, Barbara ^b   Missiaglia, Edoardo ^b   Bernardi, Francesco ^b   Rodeghiero, Francesco ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b NONE

Author keywords

APC resistance; Factor V; FV Leiden; Inherited thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; ARGININE; BLOOD CLOTTING FACTOR 5; GLUTAMINE; HISTIDINE;

AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOPHILIA; THROMBOSIS;

EID: 0030698229     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3993213.x     Document Type: Article

References (14)

1. Bertina, R.M., Koeleman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
2. Bertina, R.M., Reitsma, P.H., Rosendaal, F.R. & Vandenbroucke, J.P. (1995) Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thrombosis and Haemostasis, 74, 449-453.
3. de Ronde, H. & Bertina, R.M. (1994) Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thrombosis and Haemostasis, 72, 880-886.
4. Greengard, J.S., Alhenc-Gelas, M., Gandrille, S., Emmerich, J., Aiach, M. & Griffin, J. (1995) Pseudo-homozygous protein C resistance due to coinheritance of heterozygous factor V-R506Q and type I factor V deficiency associated with thrombosis. (Abstract). Thrombosis and Haemostasis, 73, 1361.
5. Jenny, R.J., Pittman, D.D., Toole, J.J., Kriz, R.W., Aldape, R.A., Hewick, R.M., Kaufman, R.J. & Mann, K.G. (1987) Complete cDNA and derived aminoacid sequence of human factor V. Proceedings of the National Academy of Sciences of the United States of America, 84, 4846-4850.
6. Lunghi, B., Iacoviello, L., Gemmati, D., DiIasio, M.G., Castoldi, E., Pinotti, M., Castaman, G., Redaelli, R., Mariani, G., Marchetti, G. & Bernardi, F. (1996) Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thrombosis and Haemostasis, 75, 45-48.
7. Rees, D.C., Cox, M. & Clegg, J.B. (1995) World distribution of factor V Leiden. Lancet, 346, 1133-1134.
8. Rodeghiero, F. & Tosetto, A. (1996) The VITA project: population-based distributions of protein C. antithrombin III, heparin-cofactor II and plasminogen: relationship with physiological variables and establishment of reference ranges. Thrombosis and Haemostasis, 76, 226-233.
9. Rosendaal, F.R., Koster, T., Vandenbroucke, J.P. & Reitsma, PH. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 85, 1504-1508.
10. Sacchi, E., Pinotti, M., Marchetti, G., Merati, G., Tagliabue, L., Mannucci, P.M. & Bernardi, F. (1995) Protein S mRNA in patients with protein S deficiency. Thrombosis and Haemostasis, 73, 746-749.
11. Shen, N.L.L., Fan, S., Pyati, J., Graff, R., LaPolla, R.J. & Edgington, T.S. (1993) The serine protease factor V is synthesized by lymphocytes. Journal of Immunology, 150, 2992-3001.
12. Simioni, P., Scudeller, A., Radossi, P., Gavasso, S., Girolami, B., Tormene, D. & Girolami, A. (1996) 'Pseudohomozygous' activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Thrombosis and Haemostasis, 75, 422-426.
13. Tosetto, A. & Rodeghiero, F. (1995) Diagnosis of APC resistance in patients on oral anticoagulant therapy. Thrombosis and Haemostdsis, 73, 732-733.
14. Zöller, B., Svensson, P.J., He, X. & Dahlbäck, B. (1994) Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. Journal of Clinical Investigation, 94, 2521-2524.